Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 5/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6689556 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL3762292 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL339526 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL6688849 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1827580 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5431993 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL2464653 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1445754 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1593662 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 | |
| Octane SCHEMBL27910076 | 1.00 | DGKA (0.55) | DGKALMNAPAMMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7591872-B1 | Method for producing silver nanoparticles and conductive ink | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2009-09-22 | — | — | US | claimed |
| US-20090223410-A1 | METHOD FOR PRODUCING SILVER NANOPARTICLES AND CONDUCTIVE INK | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2009-09-10 | — | — | US | claimed |
| CN-113083355-B | Fe-ZSM-5 catalyst and preparation method and application thereof | 中国海洋石油集团有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2021104770-A1 | ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND GLYCERYL STEARATE CITRATE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE COMBINATIONS | BEIERSDORF AG (DE) | 2021-06-03 | — | — | WO | disclosed |
| CN-104997803-B | Comprising the treatment using magnetic dipole stabilizing solutions or improves disease and enhance the method and composition of performance | 雷文制药有限公司 | 2019-07-09 | — | — | CN | disclosed |
| CN-102869777-B | CSF3 relevant diseases are treated by inhibiting the natural antisense transcript of colony stimulating factor 3 (CSF3) | 库尔纳公司 | 2018-11-02 | — | — | CN | disclosed |
| CN-108420827-A | Include the composition and application thereof of magnetic dipole stabilizing solutions | 雷文制药有限公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-103327986-B | Methods of treating or ameliorating diseases and enhancing performance comprising use of magnetic dipole stabilized solutions | 雷文制药有限公司 | 2018-05-25 | — | — | CN | disclosed |
| CN-107921113-A | Immunomodulatory compositions and methods of use thereof | 巴比塔·阿格拉沃尔 | 2018-04-17 | — | — | CN | disclosed |
| CN-107670044-A | Comprising the treatment using magnetic dipole stabilizing solutions or improve disease and strengthen the method for performance | 雷文制药有限公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-102971423-B | MSRA relevant diseases are treated by suppressing Methionine Sulfoxide Reductase A (MSRA) natural antisense transcript | 库尔纳公司 | 2018-01-26 | — | — | CN | disclosed |
| US-6146857-A | CULTURING VIABLE IN NUTRIENT MEDIUM, THEN IN MATURATION MEDIUM TO TRANSFORM THE CARBON SOURCE INTO INTRACELLULAR GLYCOGENS, STOPPING METABOLISM OF YEAST, DISINTEGRATING MEMBRANES, PRECIPITATING AND RECOVERING GLYCOGENS | LABORATOIRES SEROBIOLOGIQUES, SOCIETE ANONYME (FR) | 2000-11-14 | — | — | US | disclosed |
| EP-0964673-A4 | PROTECTIVE AGENTS FOR SKIN AND HAIR | TAKASAGO PERFUMERY CO LTD (JP) | 2000-07-05 | — | — | EP | disclosed |
| WO-2000032176-A2 | USE OF 17-KETOSTEROIDS FOR THE TREATMENT OF TOXOPLASMOSIS AND CRYPTOSPORIDOSIS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032201-A2 | USE OF 17-KETOSTEROIDS FOR THE TREATMENT OF MALARIA AND TRYPANOSOMIASIS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032177-A2 | USE OF 17-KETOSTEROIDS IN THE TREATMENT OF HEPATITIS C VIRUS AND OTHER TOGAVIRUS INFECTIONS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0964673-A1 | PROTECTIVE AGENTS FOR SKIN AND HAIR | Takasago International Corporation (JP) | 1999-12-22 | — | — | EP | disclosed |
| WO-1998027958-A1 | PROTECTIVE AGENTS FOR SKIN AND HAIR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-07-02 | — | — | WO | disclosed |
| US-4162241-A | NEUTRALIZED SULFONATED BUTYL RUBBER OR DIENE-ETHYLENE-PROPYLENE TERPOLYMER | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-07-24 | — | — | US | disclosed |
| US-4091170-A | VINYLIDENE CHLORIDE COPOLYMER, ALKALI METAL LAURYL SULFATE, STEARATE SALT | OLIN CORPORATION (US) | 1978-05-23 | — | — | US | disclosed |